The HIV Prevention Research Advocacy Fellows Program pairs emerging leaders in advocacy and activism with existing organizations to develop and execute creative, context-specific projects focused on HIV prevention research.
biomedical HIV prevention interventions
The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention
Most HIV transmissions among men who have sex with men (MSM), the group that accounted for 67% of new US infections in 2014, occur via exposure to the rectal mucosa. However, it is unclear how the act of condomless receptive anal intercourse (CRAI) may alter the mucosal immune environment in HIV-negative MSM. Here, we performed a comprehensive characterization of the rectal mucosal immune environment for the phenotype and production of pro-inflammatory cytokines by CD4 and CD8 T cells, global transcriptomic analyses, and the composition of microbiota in HIV-negative MSM.
Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis
Men who have sex with men (MSM) have been affected disproportionately by the global HIV pandemic. Rates of consistent condom-use are low and there is a need for further biomedical prevention interventions to prevent new HIV infections. Post exposure prophylaxis (PEP) can reduce the risk of HIV, but uptake among MSM is low. Pre-exposure prophylaxis (PrEP), an innovative antiretroviral-based HIV prevention tool might be an appropriate intervention for MSM who have recently accessed PEP that involves HIV negative individuals taking daily tenofovir+emtricitabine for HIV prevention.
This year’s AVAC Report takes on one of the most urgent issues facing biomedical HIV prevention today: gaps in the type and quality of data collected on prevention for HIV-negative people. Globally, the number of new HIV infections is not declining. In the places where gains have been made, continued progress is not guaranteed. Fixing core problems with how prevention data are collected and reported is key to slowing the rate of new cases of HIV.
Announcing the Call for 2017 Fellows
AVAC is pleased to announce the call for applications for 2017 Advocacy Fellows. Consider applying to be an Advocacy Fellow and join the 50 Fellows and alumni of the program!
This update provides information on the Advocacy Fellows program, the application process, link to a short informational video and details on an upcoming informational call for interested applicants to be held on Thursday, 7 July 2016.
The submission deadline for Advocacy Fellows applications is Monday, 15 August 2016.
Stigma, ambivalence and other priorities – explaining poor adherence to PrEP and vaginal microbicides
Qualitative study examines low uptake among South African women in VOICE study